TY - JOUR AU - Tella, Sri Harsha AU - Kommalapati, Anuhya AU - Singhi, Ryan K. PY - 2018 TI - Cost-effectiveness in managing skeletal related events in breast cancer: a strategy of less-intense dosing schedule of bone modifying agents JF - Translational Cancer Research; Vol 7, Supplement 1 (February 06, 2018): Translational Cancer Research Y2 - 2018 KW - N2 - The introduction of bone-modifying agents (BMA) or skeletal protective agents in the mid 1990’s into oncology armamentarium has revolutionized the management of skeletal related events (SREs) in cancer patients with established bone metastases. The health and financial burden of SREs are significantly reduced with the use of adjuvant BMAs. UR - https://tcr.amegroups.org/article/view/18411